|
|||||
|
|
Enzalutamide for treatment of CRPC: Rationale for sequencing and potential clinical biomarker for resistance |
|
| Authors: | Sarah E Lochrin William D Figg II Stephen P Finn |
| Institution: | Trinity College Dublin; University of Dublin; Dublin, Ireland |
| Abstract: | |
| Keywords: | Androgen receptor hormonal therapy prostate cancer resistance splice-variants testosterone |